The United States is and has led the international pharmaceutical market for many years, so slowed growth here may signal bad news for the global economy. A QuintilesIMS report indicates that market growth in the US will slow to single digits, between 6% and 9%, through 2021, which is down from a 12% growth in 2015. The sluggish market growth is attributed to hepatitis and cancer drugs that are expected to have less of an impact in coming years.
Still, the US will remain the world’s largest pharmaceutical market, contributing 53% of all forecasted growth within the next five years. China is expected to continue in the second-largest spot by contributing 12% of the world’s pharmaceutical growth.
Healthcare spending continues to cause challenges across all health sectors. Spending in the US hit $3.3 trillion (17.8 percent of the GDP) in 2016. In fact, expenditures on drug advertisements have quadrupled since 2000. From administrative burdens and low-value care to overtreatment and archaic payment mechanisms, there is a significant amount of waste in the system.
64% of physicians believe that 15%-30% of medical care is not needed according to a Johns Hopkins University survey of 1,206 physician-members of the American Medical Association. On average, the response from physicians was that 20.6 percent of overall medical care is unnecessary, including 24.9 percent of tests, 22 percent of prescription medications and 11.1 percent of procedures.
On average, two-thirds of employees are positively engaged at work. Employees in the United States, and those working in biotechnology and medical devices are the most engaged, whereas employees in Asia Pacific countries have lower than average engagement levels, as do employees at pharmaceutical and contract research organizations (CROs).
A 2018 study by ProClinical found that life sciences companies were good at giving their employees recognition for their efforts and achievements (57%) which was one of the top 5 motivators, although there is certainly opportunity here to make employees feel more valued. Also, career support and development opportunities were reported as a relatively significant influencer (11%) yet only 46% of employees said that they received adequate opportunities at their current company.